Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Cyclerion Therapeutics patents

Patents where

Current Assignee

Name

Cyclerion Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11389449 Treatment of metabolic syndrome with an sGC stimulator		Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11389449	July 19, 2022
‌ US Patent 10517874 sGC stimulators	Patent 10517874 was granted and assigned to Cyclerion Therapeutics on December, 2019 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	10517874	December 31, 2019
‌ US Patent 11357777 Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)	Patent 11357777 was granted and assigned to Cyclerion Therapeutics on June, 2022 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11357777	June 14, 2022
‌ US Patent 11180493 SGC stimulators	Patent 11180493 was granted and assigned to Cyclerion Therapeutics on November, 2021 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11180493	November 23, 2021
‌ US Patent 11274096 Processes and intermediates for the preparation of soluble guanylate cyclase stimulators	Patent 11274096 was granted and assigned to Cyclerion Therapeutics on March, 2022 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11274096	March 15, 2022
‌ US Patent 10889577 Solid forms of an sGC stimulator	Patent 10889577 was granted and assigned to Cyclerion Therapeutics on January, 2021 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	10889577	January 12, 2021
‌ US Patent 10927136 Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators	Patent 10927136 was granted and assigned to Cyclerion Therapeutics on February, 2021 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	10927136	February 23, 2021
‌ US Patent 11319308 Processes for preparation of soluble guanylate cyclase stimulators	Patent 11319308 was granted and assigned to Cyclerion Therapeutics on May, 2022 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11319308	May 3, 2022
‌ US Patent 10472363 SGC stimulators	Patent 10472363 was granted and assigned to Cyclerion Therapeutics on November, 2019 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	10472363	November 12, 2019
‌ US Patent 10844064 sGC stimulators	Patent 10844064 was granted and assigned to Cyclerion Therapeutics on November, 2020 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	10844064	November 24, 2020
‌ US Patent 11572358 Solid forms of an sGC stimulator	Patent 11572358 was granted and assigned to Cyclerion Therapeutics on February, 2023 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11572358	February 7, 2023
‌ US Patent 10639308 sGC stimulators	Patent 10639308 was granted and assigned to Cyclerion Therapeutics on May, 2020 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	10639308	May 5, 2020
‌ US Patent 11466015 Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulators	Patent 11466015 was granted and assigned to Cyclerion Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11466015	October 11, 2022
‌ US Patent 11466014 Process for preparing soluble guanylate cyclase stimulators	Patent 11466014 was granted and assigned to Cyclerion Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11466014	October 11, 2022
‌ US Patent 10858363 SGC stimulators	Patent 10858363 was granted and assigned to Cyclerion Therapeutics on December, 2020 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	10858363	December 8, 2020
‌ US Patent 11207323 sGC stimulators	Patent 11207323 was granted and assigned to Cyclerion Therapeutics on December, 2021 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11207323	December 28, 2021
‌ US Patent 11690828 Treatment of CNS diseases with sGC stimulators		Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11690828	July 4, 2023
‌ US Patent 11708361 Processes and intermediates for the preparation of soluble guanylate cyclase stimulators		Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11708361	July 25, 2023
‌ US Patent 11773089 Process for preparation of soluble guanylate cyclase stimulators	Patent 11773089 was granted and assigned to Cyclerion Therapeutics on October, 2023 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11773089	October 3, 2023
‌ US Patent 11834444 Processes for preparation of soluble guanylate cyclase stimulators	Patent 11834444 was granted and assigned to Cyclerion Therapeutics on December, 2023 by the United States Patent and Trademark Office.	Cyclerion Therapeutics	Cyclerion Therapeutics	United States Patent and Trademark Office	11834444	December 5, 2023

20 results

0 selected

20 results

0 selected